Moneycontrol PRO
Loans
Loans
HomeNewsGlenmarkpharma

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Buy Reliance Industries, M&M may move to Rs 1340-1350: Mitessh Thakkar

    Mitessh Thakkar of mitesshthakkar.com suggests buying Reliance Industries.

  • Prefer Glenmark Pharma, Sun Pharmaceutical, Lupin: Sharmila Joshi

    Sharmila Joshi of sharmilajoshi.com is of the view that is of the view that one may prefer Glenmark Pharma, Sun Pharmaceutical and Lupin.

  • Buy, Sell, Hold: 7 stocks and 1 sector are on analysts’ radar today

    NTPC, Glenmark and GAIL, among others, are being tracked by investors on Monday.

  • Buy Glenmark Pharma, Ajanta Pharma, Cipla: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Glenmark Pharma, Ajanta Pharma and Cipla.

  • Nomura sees 45% upside in Glenmark share price on US launches, outlicensing deals

    The research house has increased its FY19/20 EPS estimates by 4/6 percent but cut FY18 EPS estimates by 5 percent.

  • Buy, Sell, Hold: 3 stocks and 4 sectors are being tracked by analysts today

    HDFC, Somany and pharma, among others, are on the radar of investors on Tuesday.

  • Here are SP Tulsian's top trading ideas

    In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.

  • Buy Apollo Tyres, DHFL, Shree Cements; sell Tata Motors, Glenmark: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one can buy Apollo Tyres, Dewan Housing Finance Corporation and Shree Cements and can sell Tata Motors and Glenmark Pharma.

  • Buy Bharat Financial, Ashok Leyland, Ambuja Cements; hold Vedanta: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one can buy Bharat Financial, Ashok Leyland and Ambuja Cements and advises holding Vedanta.

  • Sell Dish TV, Glenmark Pharma; buy HDFC Bank, L&T, PVR, GAIL, Petronet: Mitessh Thakkar

    Mitessh Thakkar of mitesshthakkar.com recommends selling Dish TV and Glenmark Pharma and advises buying HDFC Bank, Larsen and Toubro and PVR.

  • Sell Glenmark Pharma; buy L&T, Indraprastha Gas: Ashwani Gujral

    According to Ashwani Gujral of ashwanigujral.com, one may buy Larsen & Toubro and Indraprastha Gas.

  • Here are some stock trading ideas from market experts

    Watch the interview of Andrew Holland CEO, Avendus Capital and Ashwani Gujral ashwanigujral.com with CNBC-TV18's Prashant Nair and Ekta Batra on CNBC-TV18, in which they shared their reading and outlook on markets and specific stocks.

  • Buy, Sell, Hold: Here are 8 stocks that analysts are tracking today

    Glenmark, L&T and HDFC Bank, among others, are on the radar of investors on Friday.

  • Buy Sobha, PC Jeweller; sell Glenmark Pharma: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com advises buying Sobha and PC Jeweller and sell Glenmark Pharma.

  • Sell Glenmark Pharma, Idea Cellular; buy Titan Company, prefer Maruti Suzuki over Amtek Auto: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one can sell Glenmark Pharma and Idea Cellular and buy Titan Company and prefers Maruti Suzuki over Amtek Auto.

  • Buy Aurobindo Pharma, Natco Pharma, Glenmark Pharma: Sudip Bandopadhyay

    Sudip Bandopadhyay, Market Expert recommends buuying Aurobindo Pharma, Natco Pharma and Glenmark Pharma and expects more than 20 percent upside in one year.

  • Bull's Eye: Sell Hindalco, Glenmark, Havells, Jubilant Food, MCX; buy Welspun Corp

    Sumeet Jain of Destimoney Securities is of the view that one may sell Multi Commodity Exchange of India (MCX) Future with a target of Rs 955.

  • Buy Jubilant Food, JSW Steel, BEML, Emami; sell Glenmark Pharma: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one can buy Jubilant Foodworks, JSW Steel, BEML and Emami and sell Glenmark Pharma.

  • Buy Tata Global, HUL; sell Lupin, Sun Pharma, Glenmark Pharma: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Tata Global Beverage and Hindustan Unilever and can sell Lupin, Sun Pharmaceutical Industries and Glenmark Pharma.

  • Buy Vedanta, Apollo Tyres; sell Tata Comm, Glenmark Pharma, UPL: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one can buy Vedanta and Apollo Tyres and sell Tata Communications, Glenmark Pharma and UPL.

  • Buy Aurobindo Pharma; like Glenmark Pharma, Natco Pharma: Sudip Bandhopadhyay

    Sudip Bandhopadhyay, Market Expert is of the view that one can buy Aurobindo Pharma and likes Glenmark Pharma as well as Natco Pharma..

  • Here are fundamental trading ideas from SP Tulsian

    In an interview to CNBC-TV18, SP Tulsian of sptulsian.com in which he shared his readings and outlook on market and specific stocks.

  • Here are SP Tulsian's top trading ideas

    In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.

  • Here are SP Tulsian's top trading ideas

    In an interview to CNBC-TV18's Surabhi Upadhyay and Prashant Nair, SP Tulsian of sptulsian shared his views and outlook on the fundamentals of the market and specific stocks.

  • Here are Surajit Pal's views on Glenmark Pharma & Biocon

    In an interview to CNBC-TV18, Surajit Pal of Prabhudas Lilladher shared his views and readings on two stocks from pharma space - Glenmark Pharma and Biocon.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347